Received Jun 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
Blurry visions; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry visions) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurry visions). At the time of the report, VISION BLURRED (Blurry visions) outcome was unknown. Concomitant medication was not provided. Patient reported same symptoms as reporter. The patient had eye examination one month prior to vaccination and had no issues with eyes. She experienced symptoms approximately two weeks post-vaccination. Her doctor attributed the condition to the moderna vaccine. She felt like Moderna was responsible for her issue as they were not given any warning, and it was Moderna responsibility to report those side effects to the public. Treatment information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-787613 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-787613:Master case (Patient 1)